To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Bone Turnover Marker Monitoring for Guiding Osteoporosis Treatment Post-TKA In Post-Menopausal Women

Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
April 2021

Bone Turnover Marker Monitoring for Guiding Osteoporosis Treatment Post-TKA In Post-Menopausal Women

Vol: 21| Issue: 1| Number:2| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

The use of bone turnover markers for monitoring the treatment of osteoporosis in postmenopausal females undergoing total knee arthroplasty: a prospective randomized study

J Orthop Surg Res. 2021 Mar 17;16(1): 195.

Contributing Authors:
R Ma M Wu Y Li J Wang P Yang Y Chen W Wang J Song K Wang

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

Sixty-four post-menopausal women with osteoporosis scheduled for a unilateral total knee arthroplasty (TKA) were randomized to receive anti-osteoporosis treatment (alendronate; calcitriol; calcium carbonate) guided by bone turnover marker monitoring (n=32) or a standard 3 month anti-osteoporosis treatment (n=32). Outcomes of interest included duration of treatment, incidence of adverse reactions t...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue